Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Revathi, Swaminathan"'
Autor:
Himasree, P., Durga, Ikkurthi Kanaka, Krishna, T.N.V., Rao, S. Srinivasa, Muralee Gopi, Chandu V.V., Revathi, Swaminathan, Prabakar, K., Kim, Hee-Je
Publikováno v:
In Electrochimica Acta 10 May 2019 305:467-473
Autor:
Revathi Swaminathan, Mark D. Hauge, Philip J. Stella, Richard Charles Tenglin, Nathan R. Foster, Michael G. Haddock, John K. Camoriano, Dennis F. Moore, James A. Martenson, Paul L. Schaefer, Steven R. Alberts
Publikováno v:
Journal of Clinical Oncology. 25:2567-2572
Purpose A phase II study was conducted to determine the efficacy and toxicity of radiotherapy with concomitant gemcitabine and cisplatin for patients with locally advanced pancreatic adenocarcinoma. Patients and Methods Forty-eight patients with loca
Autor:
John W. Kugler, Philip J. Stella, Georgene Schroeder, Patrick A. Burch, Roger G. Santala, James A. Martenson, Graciela R. Garton, Revathi Swaminathan, Henry C. Pitot, Keith Wright
Publikováno v:
International journal of radiation oncology, biology, physics. 37(3)
Purpose: The purpose of this study was to develop a satisfactorily tolerated regimen of radiation therapy, continuous infusion 5-fluorouracil, and leucovorin in patients with locally advanced upper-abdominal gastrointestinal cancer. Methods and Mater
Autor:
Mark D. Hauge, Revathi Swaminathan, Nathan R. Foster, Steven R. Alberts, Richard M. Goldberg, James A. Martenson, Michael G. Haddock
Publikováno v:
Journal of Clinical Oncology. 22:4121-4121
4121 Background: In vitro studies suggest that low dose GEM sensitizes cells to RT for 48 hours following exposure. CIS is a radiation sensitizer and may result in synergistic cytotoxicity when combined with GEM. This phase II study was conducted to
Autor:
Revathi Swaminathan, Paul L. Schaefer, Graciela R. Garton, Georgene Schroeder, Roger G. Santala, James A. Martenson, John W. Kugler, Henry C. Pitot, Keith Wright, Patrick A. Burch, A.K. Hatfield
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 32:265